Radiofrequency ablation techniques to cure cardiac arrhythmias have focused on destroying myocardial tissue involved in abnormal excitation or conduction. This review will address recent basic and clinical studies which suggest that targeting autonomic nerves and ganglia on the large vessels and the heart, within the pericardium, can result in cardiac arrhythmia suppression with little, if any, damage to healthy myocardium. Basic reports have shown that electrical stimulation of autonomic nerves on the heart itself can facilitate the induction of atrial fibrillation. The initial investigations found that the lowest threshold for inducing atrial fibrillation was at the entrances of the pulmonary veins. Moreover, beta-blockade blunted this response whereas atropine abolished atrial fibrillation inducibility. Subsequent studies found that ganglionated plexi clustered at the pulmonary vein entrances (within fat pads) could be stimulated without atrial excitation. Now, premature beats induced in the pulmonary veins could be converted to atrial fibrillation with a significantly greater propensity than without ganglionated plexi stimulation. Furthermore, ablation of these ganglionated plexi abolished atrial fibrillation inducibility. Clinical studies have been forthcoming clearly implicating these intrinsic cardiac ganglia in clinical atrial fibrillation. Previous ablation procedures have focused on destroying myocardial sites that participated in the initiation and perpetuation of various tachyarrhythmias. New basic and clinical findings may allow targeting autonomic elements at a few specific sites on the heart that are directly related to arrhythmia formation, thereby reducing extensive damage to healthy myocardium.
23 September 2008 in Journal of Interventional Cardiac Electrophysiology
Background-The objective of this study was to develop an acute experimental model showing both focal and macroreentrant sustained atrial fibrillation (AF). Methods and Results-In 31 anesthetized dogs, bilateral thoracotomies allowed the attachment of electrode catheters at the right and left superior pulmonary veins, atrial free walls, and atrial appendages. Acetylcholine, 100 mmol/L, was applied topically to either appendage. Sequential radiofrequency ablation was achieved for the ganglionated plexi (GP), found adjacent to the 4 pulmonary veins. In 12 separate studies, a propafenone bolus, 2 mg/ kg, was given before and after GP ablations at the start of acetylcholine-induced AF. Acetylcholine caused abrupt onset of AF (n = 22) or induced AF by burst pacing (n = 9) that lasted >= 10 minutes. Rapid, regular, or fractionated atrial electrograms were consistently seen (average cycle length, 37 +/- 7 ms) at the appendages versus cycle lengths of 114 +/- 23 ms at other atrial sites. After ablations of GP, AF abruptly terminated (n = 25). In 6 dogs, sustained atrial tachyarrhythmias continued. Pacing at specific atrial sites organized electrograms of one atrium or also captured the other atrium. The latter resulted in termination when pacing was stopped in 4 of these 6 experiments. Propafenone did not change the duration of focal AF before GP ablation (17 +/- 9 versus 14 +/- 8 minutes; control, P = 0.6) but terminated reentrant atrial tachyarrhythmias (12 +/- 3 versus 2 +/- 1 minutes, P = 0.0009). Conclusions-Before GP ablation, acetylcholine (100 mmol/L) induced sustained AF characterized by rapid, focal firing. GP ablations were associated with loss of focal firing and regularization of electrograms in both atria before termination. Propafenone failed to terminate focal AF but rapidly terminated entrainable macroreentrant atrial tachyarrhythmias. (Circ Arrhythmia Electrophysiol. 2009;2:384-392.)